High IL-1β expression has been shown to enhance pro-inflammatory signaling in TP53-mutant tumors, promote PD-L1 upregulation and immune evasion, and support tumor progression through angiogenesis and recruitment of myeloid-derived suppressor cells and tumor-associated macrophages [15,29,44,45,46,47]. The gene discussed is TP53; the disease is neoplasm.